InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
0.00%
)
Bitcoin
63,893.95
(
-0.55%
)
Post# of 252302
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

xavierprivas

Send PM Follow Ignore
Followers 6
Posts 162
Boards Moderated 0
Alias Born 09/14/2009

xavierprivas

Re: Whalatane post# 232328

Thursday, 05/14/2020 10:22:42 AM

Thursday, May 14, 2020 10:22:42 AM

Post# of 252302

IMO $MGNX shows better result. MGC018 =50% PSA reduction in 5/7 mCRPC
patients included all 7 mCRPC patients enrolled in 4 dose
escalation cohorts of 0.5 mg/kg to 3 mg/kg unlike $ARVN ARV-110 =50% PSA
reduction in 2/8 patients dosed at 140mg only. No response for 280mg dose.

Also $ARVN ARV-110 has renal toxicity. No position in either, just following. Do your own DD.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up